QUOTE AND NEWS
Globe Newswire  May 15  Comment 
MILTON, Ga., May 15, 2012 (GLOBE NEWSWIRE) -- Exide Technologies (Nasdaq:XIDE) (www.exide.com), a global leader in stored electrical energy solutions, announced today that it will host a conference call on June 8, 2012 to discuss its financial
The Hindu Business Line  Apr 30  Comment 
Exide Industries Ltd posted 13 per cent drop in net profit to Rs 143 crore for the quarter ended March 31 compared with Rs 164 crore in the same period last year. On a sequential basis,...
The Economic Times  Apr 30  Comment 
ET Now spoke to dealers on institutional and high net worth investors' activity in the dealing room. The following stocks were on their radar on unconfirmed reports.
Reuters  Apr 18  Comment 
Reuters Market Eye - Shares in Exide Industries fell 2.2 percent after the company cut prices for some of its batteries, which traders saw as a measure intended to sacrifice profit margins by seeking to boost sluggish sales.
Benzinga  Mar 5  Comment 
Stifel Nicolaus resumes coverage on Exide Technologies (NASDAQ: XIDE) with a Hold, reflecting the company's challenges on cost and customer retention. Stifel Nicolaus says, "The company benefited significantly from aggressive restructuring...
Benzinga  Feb 13  Comment 
According to a research report published today by Wedbush, Exide Technologies (NASDAQ: XIDE) recently reported a large 3Q12 miss. Wedbush broke it down in the report: “3Q12 Rev/GAAP-EPS was $784.1m/$0.84 vs. our estimates of $877.9m/$0.24. ...
Globe Newswire  Feb 13  Comment 
MILTON, Ga., Feb. 13, 2012 (GLOBE NEWSWIRE) -- Exide Technologies (Nasdaq:XIDE), a global leader in stored electrical energy, announces the appointment of Carla Chaney as Executive Vice President, Human Resources. Since 2010, Chaney has been Group
Benzinga  Feb 10  Comment 
(c) 2011 Benzinga.com. All rights reserved. This material may not be published in its entirety or redistributed without the approval of Benzinga.
Benzinga  Feb 10  Comment 
Shares of Exide Technologies (NASDAQ: XIDE) are seeing much pressure during Friday's trading session after the company reported third quarter results yesterday, which failed to thrill investors. Exide's fiscal 2012 third quarter consolidated...
StreetInsider.com  Feb 9  Comment 
NeurogesX (Nasdaq: NGSX) 25% LOWER; today announced that the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) to the U.S. FDA did not recommend FDA approval of a new indication for Qutenza® (Capsaicin) 8% patch for the...





You may also be interested in articles related to Exide Technologies (XIDE):
 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki